Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer
Clinical trial NCT01633541 · COMPLETED
Trial details
- NCT number
- NCT01633541
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2021-11-06
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.